Stock Events

Acadia Pharmaceuticals (ACAD) Q2 2016 Earnings

5MayConfirmed
Q3 2015
Q4 2015
Q1 2016
Q2 2016
-0.45
-0.42
-0.38
-0.35

Details

Expected EPS
-0.43
Actual EPS
-0.45
Surprise EPS
-0.02
Surprise Percent
+4.65%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.45 per share for Q2 2016.

0 Comments

Share your thoughts